KIR2DL1; CD158A; KIR-K64; KIR221; NKAT; NKAT1; p58.1
ORF of killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 (KIR2DL1) in pEnter, with C terminal Flag and His tag.
C3orf55
ORF of chromosome 3 open reading frame 55 (C3orf55), transcript variant 1 in pEnter, with C terminal Flag and His tag.
PIR;
ORF of pirin (iron-binding nuclear protein) (PIR), transcript variant 1 in pEnter, with C terminal Flag and His tag.
XKRY; XKRY1; XKRY2
Homo sapiens XK, Kell blood group complex subunit-related, Y-linked (XKRY), mRNA.
CAPZA1; CAPPA1; CAPZ; CAZ1
ORF of capping protein (actin filament) muscle Z-line, alpha 1 (CAPZA1) in pEnter, with C terminal Flag and His tag.
SP110; FLJ22835; IFI41; IFI75; IPR1; VODI
ORF of SP110 nuclear body protein (SP110), transcript variant b in pEnter, with C terminal Flag and His tag.
NLRP1
ORF of NLR family, pyrin domain containing 1 (NLRP1), transcript variant 2 in pEnter, with C terminal Flag and His tag.
2019-nCoV 新型冠状病毒 Spike(RBD) ORF mammalian expression plasmid (Codon Optimized)
义翘神州成功表达新冠病毒重要靶点S蛋白（S胞外区，S1，S2，S1-RBD）和N蛋白，与诊断试剂公司共同研发胶体金抗体免疫检测试剂，已通过应急审批。义翘神州还成功制备新冠病毒S蛋白和N蛋白的单克隆抗体，完成蛋白检测试剂盒的研发。